The anomalous effect of COVID-19 pandemic restrictions on the duration of untreated psychosis
- PMID: 39628123
- PMCID: PMC11698182
- DOI: 10.1192/bjo.2024.813
The anomalous effect of COVID-19 pandemic restrictions on the duration of untreated psychosis
Abstract
We investigated the impact of COVID-19 restrictions on the duration of untreated psychosis (DUP). First-episode psychosis admissions (n = 101) to the STEP Clinic in Connecticut showed DUP reduction (P = 0.0015) during the pandemic, with the median reducing from 208 days pre-pandemic to 56 days in the early pandemic period, and subsequently increasing to 154 days (P = 0.0281). Time from psychosis onset to antipsychotic prescription decreased significantly in the pandemic (P = 0.0183), with the median falling from 117 to 35 days. This cohort study demonstrates an association between greater pandemic restrictions and marked DUP reduction, and provides insights for future early detection efforts.
Keywords: COVID 19; Psychotic disorders/schizophrenia; duration of untreated psychosis; first-episode psychosis; pathways to care.
Conflict of interest statement
None.
Figures

Update of
-
The Anomalous Effect of COVID-19 Pandemic Restrictions on the Duration of Untreated Psychosis (DUP).medRxiv [Preprint]. 2024 May 9:2024.05.09.24306737. doi: 10.1101/2024.05.09.24306737. medRxiv. 2024. Update in: BJPsych Open. 2024 Dec 04;10(6):e216. doi: 10.1192/bjo.2024.813. PMID: 38766117 Free PMC article. Updated. Preprint.
References
-
- O'Donoghue B, Collett H, Boyd S, Zhou Y, Castagnini E, Brown E, et al. The incidence and admission rate for first-episode psychosis in young people before and during the COVID-19 pandemic in Melbourne, Australia. Aust N Z J Psychiatry 2022; 56(7): 811–7. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources